Literature DB >> 26611232

Screening for gastric cancer in Western countries.

Iris Lansdorp-Vogelaar1, Ernst J Kuipers2.   

Abstract

Entities:  

Keywords:  CANCER PREVENTION; GASTRIC CANCER; SCREENING

Mesh:

Substances:

Year:  2015        PMID: 26611232     DOI: 10.1136/gutjnl-2015-310356

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

1.  Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans.

Authors:  Christie Y Jeon; Yu-Chen Lin; Samuel J Klempner; Bechien U Wu; Sungjin Kim; Kevin M Waters; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-19

2.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

3.  Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program.

Authors:  Xuan Quy Luu; Kyeongmin Lee; Jae Kwan Jun; Mina Suh; Kyu-Won Jung; Kui Son Choi
Journal:  J Gastroenterol       Date:  2022-05-14       Impact factor: 7.527

4.  EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.

Authors:  Hai-Ting Liu; Sen Liu; Lei Liu; Ran-Ran Ma; Peng Gao
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

5.  Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.

Authors:  Liping Sun; Huakang Tu; Tiejun Chen; Quan Yuan; Jingwei Liu; Nannan Dong; Yuan Yuan
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

6.  miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.

Authors:  Kai Yin; Minghui Liu; Mei Zhang; Feng Wang; Min Fen; Zhijian Liu; Yutao Yuan; Shanting Gao; Liuqing Yang; Weijie Zhang; Jianguo Zhang; Baoliang Guo; Jianwei Xu; Hongwei Liang; Xi Chen; Wenxian Guan
Journal:  Oncotarget       Date:  2016-10-11

7.  Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013.

Authors:  Zhaolai Hua; Xianzhi Zheng; Hengchuan Xue; Jianming Wang; Jun Yao
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

8.  miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.

Authors:  Xiuting Hu; Yanbo Wang; Hongwei Liang; Qian Fan; Ruichi Zhu; Jiayi Cui; Weijie Zhang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Zhen Zhou; Xi Chen
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

9.  Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.

Authors:  Xi Liu; Xiaodong Wei; Wei Niu; Dong Wang; Bo Wang; Hao Zhuang
Journal:  Mol Med Rep       Date:  2018-09-07       Impact factor: 2.952

10.  SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion.

Authors:  Hongjie Sun; Dongli Huang; Guozheng Liu; Fengguo Jian; Jianfang Zhu; Lixia Zhang
Journal:  Onco Targets Ther       Date:  2018-07-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.